搜尋
Arcellx Inc
ACLX添加自選
115.070USD
0.0000.00%
收盤 06/30, 16:00（美東）報價延遲15分鐘
6.73B總市值
虧損本益比TTM
股東統計
更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Gilead Sciences, Inc
11.49%
Vanguard Capital Management, LLC
4.15%
Vanguard Portfolio Management, LLC
4.15%
State Street Investment Management (US)
3.42%
T. Rowe Price Associates, Inc.
2.69%
其他
74.10%
持股股東
持股股東
佔比
Gilead Sciences, Inc
11.49%
Vanguard Capital Management, LLC
4.15%
Vanguard Portfolio Management, LLC
4.15%
State Street Investment Management (US)
3.42%
T. Rowe Price Associates, Inc.
2.69%
其他
74.10%
股東類型
持股股東
佔比
Investment Advisor
21.80%
Investment Advisor/Hedge Fund
12.92%
Corporation
11.49%
Hedge Fund
8.43%
Research Firm
2.86%
Venture Capital
1.07%
Bank and Trust
0.47%
Pension Fund
0.18%
Sovereign Wealth Fund
0.03%
其他
40.75%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
483
22.60M
38.64%
-31.29M
2025Q4
441
60.19M
107.73%
+3.27M
2025Q3
457
56.92M
115.34%
-1.91M
2025Q2
440
55.23M
110.30%
-248.28K
2025Q1
433
55.56M
106.71%
-3.07M
2024Q4
424
53.15M
105.55%
+1.98M
2024Q3
391
50.27M
106.69%
-1.02M
2024Q2
368
52.42M
103.43%
+3.23M
2024Q1
351
49.13M
103.29%
-5.40M
2023Q4
314
49.14M
109.15%
-782.40K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Gilead Sciences, Inc
6.72M
11.49%
--
--
Feb 23, 2026
State Street Investment Management (US)
2.00M
3.42%
+472.48K
+30.96%
Dec 31, 2025
T. Rowe Price Associates, Inc.
1.57M
2.69%
+344.40K
+28.00%
Dec 31, 2025
Citadel Advisors LLC
1.50M
2.57%
+478.77K
+46.87%
Dec 31, 2025
JP Morgan Asset Management
1.23M
2.1%
+578.50K
+89.01%
Dec 31, 2025
Geode Capital Management, L.L.C.
958.06K
1.64%
+31.75K
+3.43%
Dec 31, 2025
Janus Henderson Investors
919.58K
1.57%
-94.34K
-9.30%
Dec 31, 2025
Woodline Partners LP
737.82K
1.26%
+496.44K
+205.66%
Dec 31, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Genomics Immunology and Healthcare ETF
4.98%
Tema Oncology ETF
4.19%
ALPS Medical Breakthroughs ETF
1.96%
Harbor Human Capital Factor US Small Cap ETF
1.38%
WisdomTree BioRevolution Fund
1.13%
State Street SPDR S&P Biotech ETF
1.08%
Virtus LifeSci Biotech Clinical Trials ETF
0.92%
iShares Health Innovation Active ETF
0.75%
Direxion Daily S&P Biotech Bull 3X Shares
0.67%
ProShares Ultra Nasdaq Biotechnology
0.49%
查看更多
iShares Genomics Immunology and Healthcare ETF
佔比4.98%
Tema Oncology ETF
佔比4.19%
ALPS Medical Breakthroughs ETF
佔比1.96%
Harbor Human Capital Factor US Small Cap ETF
佔比1.38%
WisdomTree BioRevolution Fund
佔比1.13%
State Street SPDR S&P Biotech ETF
佔比1.08%
Virtus LifeSci Biotech Clinical Trials ETF
佔比0.92%
iShares Health Innovation Active ETF
佔比0.75%
Direxion Daily S&P Biotech Bull 3X Shares
佔比0.67%
ProShares Ultra Nasdaq Biotechnology
佔比0.49%
